Leerink Starts Larimar Therapeutics (LRMR) at Outperform
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Price: $3.79 -0.26%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Leerink analyst Joseph Schwartz initiates coverage on Larimar Therapeutics (NASDAQ: LRMR) with a Outperform rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Larimar Therapeutics click here. For more ratings news on Larimar Therapeutics click here.
Shares of Larimar Therapeutics closed at $3.92 yesterday.
You May Also Be Interested In
- CLSA Starts HD Hyundai Electric Co Ltd (267260:KS) at Outperform (2)
- Evercore ISI Starts Prelude Therapeutics (PRLD) at Outperform
- Wells Fargo Starts Savers Value Village Inc (SVV) at Equal Weight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
